New Hope For Lung Cancer Patients — FDA Approves Drug Combination Opdivo And Yervoy For First Course Treatment

Published Jun 1, 2020

New Hope For Lung Cancer Patients — FDA Approves Drug Combination Opdivo And Yervoy For First Course Treatment

A new drug combination has been approved by the FDA for the treatment of lung cancer. This marks a historic development in research, but an expert says there's still more to be done

NOW
PLAYING
In Certain Types of Lung Cancer, Targeted Drug Tagrisso Slashed Recurrence Rates, New Study Says
NOW
PLAYING
Finally Some Progress For Esophageal Cancer Patients-- Two Immunotherapy Drugs Are Boosting Survival
NOW
PLAYING
New Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back
NOW
PLAYING
Comprehensive Biomarker Testing for Lung Cancer Points Docs to the Right Drug
NOW
PLAYING
Is Medical Marijuana Right for People With Lung Cancer?
NOW
PLAYING
HER2-Positive Metastatic Breast Cancer Treatment Options
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.